The Federal Trade Commission just released a report highlighting many of the problems of the Big 3 PBMs. The TLDR version – Big PBMs use opaque practices focused on their bottom line, not helping your company save money. Transparent PBMs, like AffirmedRx, work to show you how to save money and help your employees. #AffirmedRx #PatientsOverProfits #FederalTradeCommission https://lnkd.in/dB67WRqk
AffirmedRx, a Public Benefit Corporation’s Post
More Relevant Posts
-
Thoughts on this? >> Biden administration says IRA negotiations will result in $6B in 2026 Medicare savings >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #biotech #productmarketing #pharmaceutical #healthcare
Biden administration says IRA negotiations will result in $6B in 2026 Medicare savings
endpts.com
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Biden administration says IRA negotiations will result in $6B in 2026 Medicare savings >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #healthcare #biotech #productmarketing
Biden administration says IRA negotiations will result in $6B in 2026 Medicare savings
endpts.com
To view or add a comment, sign in
-
Congress punts on PBM reform, while class action attorneys heat up with breach of fiduciary duty lawsuits. As stated in the plaintiff's suit against J&J: "30. Fiduciaries must also ensure that their agreements with service providers and the amounts they pay to those service providers are reasonable. Fiduciaries must make a diligent effort to compare alternative service providers in the marketplace, seek the lowest level of costs for the services to be provided, and continuously monitor plan expenses to ensure that they remain reasonable under the circumstances. Fiduciaries also cannot ignore the power their plans wield to obtain favorable rates. Put simply, wasting beneficiaries’ money is imprudent. 31. Fiduciaries cannot discharge their fiduciary duties simply by relying on the advice of third-party service providers, consultants, or experts..." https://lnkd.in/eTn4D9_6
Congress punts on PBM reform efforts
https://www.statnews.com
To view or add a comment, sign in
-
Health Rosetta advisor disrupting healthcare status-quo to lower cost & improved member health with independent data.
Partially designed to allow spread-pricing profit to fund indigent care. Selling to poor members at full mark-up needs be prohibited, however reimbursed by insurance companies at mark-up is an original goal. https://lnkd.in/er253as2
Missouri is in the center of a national drug pricing battle — with billions on the line
kcur.org
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Medicare negotiations have concluded. What's next for court cases against the IRA? >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #productmarketing #healthcare #biotech
Medicare negotiations have concluded. What's next for court cases against the IRA?
endpts.com
To view or add a comment, sign in
-
The 2025 MA and Part D rule has been finalized. This is substantially what was proposed. Lots here on brokers and agents, D-SNPs, and more. Analysis to come. Dig in. https://lnkd.in/eYnCABhd #medicareadvantage
Public Inspection: Medicare Program: Medicare Advantage and the Medicare Prescription Drug Benefit Program for Contract Year 2024--Remaining Provisions and Contract Year 2025 Policy and Technical Changes to the Medicare Advantage Program, etc.
federalregister.gov
To view or add a comment, sign in
-
Update on the Federal Trade Commission 6(b) investigation into PBM business practices. Letter from FTC to Sen. Grassley: "Although our compulsory orders were issued in June 2022, and May and June 2023, to date no company has turned over sufficient documents and data to be in full compliance with those orders. FTC staff continues to push the PBM/GPOs to finalize their production of documents and data required by the Orders as quickly as possible. The respondents have proceeded with varying levels of speed in their productions and compliance with the Orders. We expect to have all the materials very soon. If, however, some of the companies fail to fully comply with the orders or engage in any actionable delaying tactics, the FTC can take them to court to compel compliance." H/T to Maya Goldman Axios for posting and writing https://lnkd.in/eEm4Zpga
FTC to Sen. Grassley - PBM 6(b) Study
https://www.documentcloud.org
To view or add a comment, sign in
-
The problem of rebates and fees…
Express Scripts' Lawsuit Reveals Striking Information About PBM Rebates - National Prescription Coverage Coalition
https://nationalprescriptioncoveragecoalition.com
To view or add a comment, sign in
-
Thoughts on this? >> Medicare negotiations have concluded. What's next for court cases against the IRA? >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #biotech #pharmaceutical #productmarketing
Medicare negotiations have concluded. What's next for court cases against the IRA?
endpts.com
To view or add a comment, sign in
-
🚨 The FTC is planning to sue the big three PBMs! 🚨 We are here now, and things are about to change. With all we’ve been through, it’s time to reset our mindset and keep fighting. Our words create reality, and God willing, we are going to get our industry back. This is just the beginning. We must continue to push, demand justice, and stand strong against those who threaten our livelihood. The fight has been long, but this is our moment. Let’s keep fighting and make our voices heard. #PBMReform #BanMailOrder
FTC to sue drug middlemen over prices of medications including insulin
cnbc.com
To view or add a comment, sign in
5,156 followers